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Abstract: Various forms of purine-nucleoside phosphorylase (PNP) were used as catalysts of 
enzymatic ribosylation of selected fluorescent 8-azapurines. It was found that the recombinant 
calf PNP catalyzes ribosylation of 2,6-diamino-8-azapurine in a phosphate-free medium, with 
ribose-1-phosphate as ribose donor, but the ribosylation site is predominantly N7 and N8, with 
the proportion of N8/N7 ribosylated products markedly dependent on the reaction conditions. 
Both products are fluorescent. Application of the E. coli PNP gave a mixture of N8 and  
N9-substituted ribosides. Fluorescence of the ribosylated 2,6-diamino-8-azapurine has been 
briefly characterized. The highest quantum yield, ~0.9, was obtained for N9-β-D-riboside  
(λmax 365 nm), while for N8-β-D-riboside, emitting at ~430 nm, the fluorescence quantum yield 
was found to be close to 0.4. Ribosylation of 8-azaguanine with calf PNP as a catalyst goes 
exclusively to N9. By contrast, the E. coli PNP ribosylates 8-azaGua predominantly at N9, 
with minor, but highly fluorescent products ribosylated at N8/N7.  
Keywords: 8-azapurines; nucleosides; enzymatic synthesis; fluorescence;  
purine-nucleoside phosphorylase 
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1. Introduction 
Enzymatic ribosylation of purine analogues has been proposed as an alternative to chemical 
synthesis of a variety of biologically active nucleosides [1–4]. We have been interested in fluorescent 
analogues of natural purine nucleosides and nucleotides, since they have found numerous applications 
in enzymology, particularly in mechanistic and dynamic studies (for reviews, see [5–7]). Among these, 
8-azapurine nucleosides are known as fluorescent species, isosteric with natural purine nucleosides, 
and may substitute for them in many biochemical processes [8,9]. They are suitable for mechanistic 
investigations, including probing of the active sites of purine-related enzymes and ribozymes [10–14], 
as well as for analytical purposes [15,16]. In the present work, we examined a possibility of enzymatic 
synthesis of ribosides of 2,6-diamino-8-azapurine (Figure 1), a highly fluorescent purine analog [17], 
using as catalysts various forms of purine-nucleoside phosphorylase (PNP, for a review see [18]), 
particularly trimeric calf PNP and hexameric E. coli PNP, and α-D-ribose-1-phosphate (R1P) as a 
ribose donor. Ribosides and deoxyribosides of 2-amino-8-azaadenine have been long ago synthesized 
by Montgomery [19] and Seela and Lampe [20], but their fluorescence properties were not described. 
The parent purine nucleoside, 2,6-diaminopurine riboside, is known to possess interesting 
biochemical properties [21–23] and was recently applied to mechanistic studies of the hairpin 
ribozyme [24], which expressed full activity when the crucial guanine residue was replaced by  
2,6-diaminopurine (Figure 1). However, 2,6-diaminopurine and its nucleoside are only moderately 
fluorescent [21], and therefore are not easily applicable to fluorescent investigations in biological 
systems. By contrast, the 2,6-diamino-8-azapurine (2-amino-8-azaadenine) ribosides and related 
compounds exhibit very intense fluorescence in neutral aqueous media, as shown below.  
Figure 1. Structures of 2,6-diamino-8-azapurine (left) and 2,6-diaminopurine. The 
compounds are shown in one of several possible tautomeric forms. Purine numbering is 
maintained in both systems for simplicity.  
 
2. Results and Discussion 
2.1. Fluorescence of 2,6-diamino-8-azapurine Base and its Alkyl Derivatives 
In contrast to the parent, weakly fluorescent 2,6-diaminopurine, its 8-aza analogue  
(2,6-diamino-8-azapurine, DaaPur), exhibits strong fluorescence in neutral aqueous medium, with a 
maximum at 365 nm and 40% yield, described in details in our previous paper [17]. This fluorescence 
was ascribed to the N(9)H protomer, on the basis of comparison with the emission properties of  
N9-alkoxyphosphono-derivative of DaaPur (see Figure 1). Other N-alkyl derivatives, N8-methyl and 
N7-methyl-DaaPur, are characterized by red-shifted UV absorption [25], and N8-methyl-DaaPur 
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additionally exhibits intense fluorescence centered at 410 nm (Figure 2). On the basis of the foregoing 
observations, we expected that ribosides of DaaPur may exhibit favorable emission properties, useful 
for analytical and structural studies.  
Figure 2. Absorption (left, solid lines) and emission (right, points) spectra of the neutral 
forms of DaaPur (green), N9-propoxyphosphono-DaaPur (blue) and N8-methyl-DaaPur 
(red) in aqueous medium, pH 6–7 (Data from [17]). Fluorescence spectra were normalized 
to the lowest-energy UV absorption bands and multiplied by the respective quantum yields. 
 
2.2. Enzymatic Ribosylation of DaaPur Using Various Forms of PNP as a Catalyst  
Although 2,6-diaminopurine, like adenine, is not a substrate for the mammalian forms of PNP in the 
reverse (synthetic) pathway [18], its 8-aza analog, DaaPur, has been found to be a modest substrate for 
both calf and E. coli PNP’s (wild types), with either ribose-1-phosphate or N7-methylguanosine as 
ribose donors. Reaction progress can be followed using UV and/or fluorescence spectroscopy, as 
shown in Figure 3 for the reaction between ribose-1-phosphate and DaaPur. The reaction rate for the 
calf enzyme at pH 6.6 is about 5% that of the 8-azaGua and ~0.4% of Gua ribosylation (see Table 1). 
For the E. coli PNP, ribosylation of DaaPur runs at ~2% of the ribosylation of guanine.  
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Figure 3. Fluorescence changes during the enzymatic ribosylation of DaaPur (~10 µM) 
with ribose-1-phosphate (0.25–0.5 mM), using recombinant E. coli (left) and calf spleen 
(right) purine-nucleoside phosphorylase as catalysts. Reactions were carried out in 25 mM 
HEPES, pH 6.6, at 25 °C, for ~1.5 h. Spectra were measured every 5 min for 30 min and 
every 20 min afterwards. Excitation wavelength was at 310 nm. 
  
Table 1. Kinetic parameters for the enzymatic ribosylation of purine analogues with 
various form of PNP as catalysts, and α-D-ribose-1-phosphate as a co-substrate. Data refer 
to pH 6.5. 
Compound Relative a kcat Km [µM] Enzyme source 
2,6-diamino-8-azapurine ~0.4% 54 calf spleen 
 2% 65 E. coli 
2,6-diaminopurine b <0.1%  - calf spleen 
 >120% c ~7 E. coli 
8-azaguanine c 21% 100 calf spleen 
 ~4 U/mg >200 E. coli 
a relative to those determined for guanine (=100%); b data from [15], at pH 7; c relative to the parameters 
determined for N7-methylguanosine phosphorolysis at pH 6.5 (=100). 
It is evident from the spectra recorded during the reaction course that in both cases the ribosylation 
product(s) involve species absorbing at ~310 nm and strongly emitting near 430 nm, thus markedly 
differing from the substrate. These products must be distinct from the typical N9-riboside, and spectrally 
resembling the N8-alkyl derivative of DaaPur (cf. Figures 2 and 3). At the endpoint of the reaction 
catalyzed by calf PNP (Figure 2B) the short-wavelength band at 365 nm virtually disappears, suggesting 
that little or no N9-riboside is produced. Occasionally, a lack of the isoemissive point was observed  
(see Figure 2), indicating existence of more than one product, likely N8- and N7-ribosides, confirmed by 
the HPLC analysis (see below). In the case of the E. coli PNP, the reaction mixture contained a marked 
component of the N9-riboside as well, emitting at ~365 nm, further documented below. 
We have separated the ribosylation products using HPLC, with C-8 column (Kromasil) in the 
reverse-phase mode, with diode array absorption detector (see Experimental section for details). The 
elution profiles, given in Figure 4, confirm that the ribosylation of DaaPur with calf PNP as a catalyst 
gives two main products, with UV absorption spectra extending much >300 nm.  
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Figure 4. Elution profiles for the HPLC analysis of the enzymatic ribosylation of DaaPur, 
catalyzed by: (a) E. coli PNP; (b) calf spleen PNP, 4 h reaction in the absence of 
phosphate; (c) calf spleen PNP, 8 h reaction in the presence of 0.5 mM phosphate. 
Detection was at 280 nm (solid line) and 315 nm (broken line). Peak near 10 min retention 
time is the substrate. 
 
Table 2. Ionization constants (pKa values) and spectral parameters for 2,6-diamino-8-
azapurine, its ribosides and selected derivatives. The UV and fluorescence spectral data for 
DaaPur and derivatives are from [8,17,19,20,25], additionally checked in the present work.  
Compound pKa 
Form 
(pH) a 
UV absorption b Fluorescence 
λmax [nm] εmax [M−1cm−1] λmax [nm] ϕ 
2,6-diamino-8-azapurine 3.68; 7.68 n (6) 280 8500 363 0.40 
  ma (10) 290 6400 370 0.36 
  cat (2.5) 253 9500 410 0.27 
N9-phoshonomethoxy-
propyl(PMP)- 
3.4 n (7) 284 nd c 367 0.80 
N8-methyl- 4.85 n (7) 307 8100 412 0.85 
  cat (2.5) 284 12000 410 ~0.4 
N7-methyl- 4.3 n (7) 309 6200 nd nd 
  cat (2) 282 7900 nd nd 
N9-β-D-ribofuranosyl- ~3.2 n (7) 286 10000 367 ~0.9 
N8-β-D-ribofuranosyl- 4.9 n (7) 313 8200 430 0.41 
N7-β-D-ribofuranosyl- 4.1 n (7) 314 ~5500 420 0.06 
a n—neutral form; cat—cation; ma—monoanion; b molar absorptivities for the ribosides has been determined relative to 
that of DaaPur, following enzymatic phosphorolysis; c nd—not determined. 
Both products are fluorescent, with emission maxima at 420–430 nm (see Table 2). The products, 
differing by the protonation constants (pKa), were identified as N8- and N7-ribosides by comparing 
spectral data with those published in refs [19,20], and with data reported for the alkyl derivatives of 
DaaPur [17]. 
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By contrast, using E. coli PNP as catalyst leads to production of two well separated and spectrally 
distinct products (Figure 3), one of which was identified as N8-riboside, identical to that produced by 
the calf PNP, and the second as N9-riboside, which was also highly fluorescent, but with maximum 
close to 367 nm, very similar to the N9-alkylated DaaPur (Table 2).  
It is interesting that the relative proportion of the products in both cases depends markedly on the 
reaction conditions, and particularly on the presence of free inorganic phosphate. When no phosphate 
was present initially, the main products were N7-riboside and N8-riboside for the reaction catalyzed by 
the calf and E. coli PNP, respectively. But when the reaction was started in the presence 0.5 mM 
phosphate, or if the reaction was allowed to proceed for 24 h, the apparent trans-ribosylation occurred, 
resulting in much higher proportion of the N8-riboside in the case of calf PNP catalysis (see Figure 4), 
and of N9-riboside in the reaction catalyzed by the E. coli enzyme (data not shown). This phenomenon 
is of interest not only from the mechanistic point of view, but also as a tool of selective synthesis of 
ribosides of DaaPur. 
2.3. Spectral and Biochemical Properties of the Ribosylation Products  
Spectral parameters of the purified ribosides, compared to those of DaaPur and its alkyl derivatives 
are summarized in Table 2. It is evident that N9-β-D-ribofuranosyl-DaaPur and N8-β-D-ribofuranosyl-
DaaPur are the most intensely fluorescent nucleosides, comparable to 2-aminopurine riboside  
(ϕ ~ 0.6 [21]), and 1,N6-ethenoadenosine (ϕ = 0.55 [26]). Since the N9-riboside is isosteric with 
natural purine nucleosides, it is particularly suitable for biophysical applications. It is also interesting that 
in acidic media both N8- and N7-riboside reveal fluorescence spectra characteristic for the neutral forms 
(data not shown), which is due to rapid deprotonation of the excited cations (to be reported elsewhere). 
We have also examined substrate properties of the DaaPur ribosides towards PNP in the presence of 
inorganic phosphate (phosphorolytic pathway). The N9-β-D-ribofuranosyl of DaaPur is not a substrate 
for the calf enzyme, similarly to the analogous riboside of 2,6-diaminopurine [18]. Only traces  
of activity were recorded for N8-β-D-ribofuranosyl-DaaPur. By contrast, the N7-isomer was 
phosphorolysed with the rate constant (kcat/Km) ca. 2% that of N7-methyguanosine phosphorolysis. All 
three ribosides were phosphorolysed by the E. coli enzyme, and the greatest rate constant was recorded 
for the N8-riboside [16]. The fluorogenic effect observed during the phosphorolysis of N7- and  
N8-ribosides may be analytically useful, as reported elsewhere [16].  
2.4. Comparison with Enzymatic Ribosylation of 8-azaguanine and Other 8-azapurines 
As previously reported [9], 8-azagauanine (8-azaGua) is effectively ribosylated using calf PNP in 
phosphate-free media, at pH ≤ 8, with either R1P or N7-methylguanosine as ribose donors. The  
E. coli PNP is a less effective catalyst, with kcat only of ~1% that for guanosine synthesis, while for the 
calf PNP this value is increased to ~20%. Until now, we have assumed, mainly on the basis of  
UV absorption spectral changes, that in both cases the only ribosylation product is 8-azaguanosine  
(N9-β-D-8-azaguanine riboside). The unexpected findings obtained for DaaPur ribosylation prompted 
us to re-examine the ribosylation of 8-azaGua, using fluorescence spectroscopy and HPLC, with 
results shown on Figure 5. The reaction was carried out at pH 7.3, which was not optimal from the 
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kinetic point of view [9], but allowed sensitive detection of the product(s) when excitation wavelength 
is set at 300 nm.  
Figure 5. Fluorescence changes recorded during the enzymatic ribosylation of 8-azaGua 
(~10 µM) catalyzed by the recombinant purine nucleoside phosphorylase from calf  
(left panel) or E. coli (right panel) PNP, with ribose-1-phosphate as a ribose donor. 
Reactions were carried out in 20 mM HEPES, pH 7.3 at 25 °C. Excitation was at 300 nm. 
  
Initially, the substrate (8-azaGua) is mostly in the anionic form (pKa 6.5), which is weakly 
fluorescent in these conditions and the observed fluorescence band with λmax 395 nm is due mostly to 
the small fraction of the neutral form present [9]. During the reaction course (Figure 5), a new band 
with a maximum at 360 nm appears, ascribed to the strongly fluorescent anionic form of the  
N9-β-D-riboside (pKa 8.0). With the reaction catalyzed by calf PNP, this is the only fluorescent 
product formed, since at the reaction endpoint the fluorescence spectrum of the final mixture is 
independent of excitation wavelength (data not shown). By contrast, when the E. coli PNP was applied 
as catalyst, the appearance of the second, minor fluorescent product was evident, since the resultant 
fluorescence was red-shifted (Figure 5B) and excitation-dependent, with emission maximum shifting 
to ~415 nm with excitation at 315 nm (data not shown). The long-wavelength fluorescence is most 
likely due to N8- and/or N7-ribosides. 
The foregoing observations were confirmed by HPLC analysis (data not shown). The reaction 
catalyzed by E. coli PNP gave clearly two nucleoside products, with spectral properties corresponding 
to N9- (major product, λmax = 256 nm) and N8-riboside (minor, highly fluorescent product). The 
proportion of two products was nearly 20:1. For the reaction catalyzed by the calf PNP, the minor peak 
was absent. 
The ribosylation site ambiguity described here for DaaPur has also been observed for 8-azaadenine 
and 8-azaisoguanine, when these were ribosylated using E. coli PNP (unpublished data), as well as for 
8-azaxanthine, when ribosylated in similar conditions using xanthosine phosphorylase from E. coli as a 
catalyst [27]. It should be recalled, at this point, that the non-typical N7-β-D- and N3-β-D-ribosides of 
natural purine bases are moderate to good substrates for both mammalian and bacterial enzymes in the 
phosphorolytic pathway [28,29], so the presence of these ribosides in the reverse reaction is not as 
surprising, as is perhaps their absence in the reactions catalyzed by the mammalian enzymes. 
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The absence of N9-riboside product during the ribosylation of DaaPur with the calf PNP is 
understandable in view of the general properties of mammalian PNP’s, which for the effective 
catalysis require interaction between purine N(1)-H, which is absent in DaaPur, and the essential 
glutamate residue of the enzyme (Glu-201 in the calf PNP) [18]. This interaction is not necessary for 
the E. coli PNP, as well in some mutants of the calf enzyme. It is difficult to explain the mechanism of 
the ribosylation at N7, not observed for the parent 2,6-diaminopurine. One possibility is binding of the 
8-azapurine substrate turned by 180 degrees around the long axis, with amine group interacting with 
Glu201 and N9 replacing N7 in interaction with Asn243 (cf. ref. [18]). 
The slow trans-ribosylation of DaaPur ribosides from N7 to N8 position, and from N8 to N9, 
observed for the reactions catalyzed by the calf and E. coli PNP, respectively, is important for 
synthetic applications, allowing selective synthesis of the required ribosides. Its mechanism is not 
clear, and probably different than that used by Mikhailopulo et al. [30] for synthesis of nucleoside 
analogs. It apparently requires the presence of both ribose-1-phosphate and free inorganic phosphate, 
and the latter does not inhibit the reaction up to concentrations of ca. 0.5 mM. The key question, 
whether this process involves repeated ribosylation-phosphorolysis cycle or perhaps some other 
activity, will be addressed in a separate paper. 
3. Experimental 
3.1. General  
Recombinant E. coli and calf spleen PNP were obtained and purified as described elsewhere [31,32].  
2,6-Diamino-8-azapurine sulfate, N7-methylguanosine and 8-azaguanine were from Sigma-Aldrich 
(St. Louis, MO, USA.), the latter was re-crystallized as a monosodium salt. N7-methylguanosine was 
used without further purification. α-D-Ribose-1-phosphate was prepared enzymatically from  
N7-methylguanosine and inorganic phosphate, and assayed by previously described fluorimetric  
method [15]. The recombinant calf PNP was used as a catalyst, and the second reaction product,  
N7-methylguanine, was removed in nearly 97% by crystallization. All buffers were of analytical grade. 
Fluorescence was measured on a Varian Eclipse instrument (Varian Corp., Palo Alto, CA, USA), using 
4-mm pathlength semi-micro cuvettes. Fluorescence quantum yields were determined either relative to 
tryptophan in water (ϕ = 0.15, [33]), or, in the case of the nucleosides, relative to DaaPur in water  
(ϕ = 0.40, [17]). The yields were determined with excitation at 280 nm, and are accurate to ±15%. 
3.2. Enzymatic Reactions and Separation of the Products 
Ribosylation of 2,6-diamino-8-azapurine and 8-azaguanine was carried out on a semi-micro scale, 
according to the following procedures: 
(1) 5 mM DaaPur, diluted from the ammonium salt solution, in 25 mM HEPES, pH 6.6, reacted 
with ~7 mM ribose-1-phosphate in 1 mL volume, at 35 °C, for 3 h. Recombinant calf PNP  
(4 µL of 12.7 mg/mL solution) was used as a catalyst. Reaction progress was monitored 
fluorimetrically. After 3 h the reaction was stopped by boiling in a microwave oven for ~20 s 
and the resultant mixture was analyzed by HPLC (see Figure 4). The overall yields of N7-β-D- 
and N8-β-D-riboside were ca. 25% and 7%, respectively. 
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(2) To the same starting solution 0.5 mM inorganic phosphate was added. The reaction was  
allowed to run for 8 h at 32 °C. Analysis of the products (Figure 4) shown ca. 40% yield of the  
N8-β-D-riboside, with ~10% yield of the N7-β-D-riboside. 
(3) Reaction was conducted for ~5 h under the conditions as indicated in (1) above, except that  
E. coli PNP was used as a catalyst. The resultant mixture contained N8-β-D-riboside  
(~30%, retention time ~17.5 min) and N9-β-D-riboside (~10%, 29–33 min). 
Products were separated by reversed-phase HPLC (RP-HPLC) on a UFLC system from Shimadzu 
(Kyoto, Japan) equipped with UV (diode-array) detection at 280 nm and 315 nm. The column used 
was a Kromasil reversed-phase analytical C8 column (250 × 4.6 mm, 5-μm particle size). The eluent 
was deionized water (solvent A) and 80% methanol in water (solvent B). The solvent program was:  
0–10 min, 100% solvent A (isocratic); 10–50 min, a linear gradient from 0 to 30% solvent B;  
50–60 min, a linear gradient to 100% solvent B; 60–70 min, 100% solvent B. 
4. Conclusions 
We have shown that 2,6-diamino-8-azapurine undergoes enzymatic ribosylation by PNP in 
phosphate-free media, and the reaction products, N9-, N8- and N7-β-D-ribofuranosides, exhibit high 
fluorescence yields, which makes them applicable in analytical and mechanistic enzymology. With 
regards to fluorescence, the N8-riboside in particular seems to be an excellent indicator of the E. coli 
PNP in biological samples, while the N7-riboside is almost specific for the mammalian enzyme [16]. 
The assays based on these compounds may be important in view of the recent application of E. coli 
PNP in cancer gene therapy in the so-called suicidal gene strategy [34]. 
Various types of PNP may be used to selectively ribosylate the nucleobase analog in the desired 
location, and, as shown in the present paper, ribosylation sites are additionally dependent on the reaction 
conditions. Although the catalysis rates in this case are rather slow, we can expect that the application of 
various mutated forms of PNP, obtained via the site-directed mutagenesis [31,35], or enzymes from 
different sources [18,36] may lead to more efficient and more selective synthetic methods. 
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